FATE
Price
$0.77
Change
+$0.01 (+1.32%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
88.24M
28 days until earnings call
SNSE
Price
$0.35
Change
+$0.01 (+2.94%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
9.21M
41 days until earnings call
Ad is loading...

FATE vs SNSE

Header iconFATE vs SNSE Comparison
Open Charts FATE vs SNSEBanner chart's image
Fate Therapeutics
Price$0.77
Change+$0.01 (+1.32%)
Volume$44.2K
Capitalization88.24M
Sensei Biotherapeutics
Price$0.35
Change+$0.01 (+2.94%)
Volume$270
Capitalization9.21M
FATE vs SNSE Comparison Chart
Loading...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FATE vs. SNSE commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FATE is a Hold and SNSE is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (FATE: $0.76 vs. SNSE: $0.34)
Brand notoriety: FATE and SNSE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FATE: 117% vs. SNSE: 21%
Market capitalization -- FATE: $88.24M vs. SNSE: $8.68M
FATE [@Biotechnology] is valued at $88.24M. SNSE’s [@Biotechnology] market capitalization is $8.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FATE’s FA Score shows that 1 FA rating(s) are green whileSNSE’s FA Score has 1 green FA rating(s).

  • FATE’s FA Score: 1 green, 4 red.
  • SNSE’s FA Score: 1 green, 4 red.
According to our system of comparison, both FATE and SNSE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FATE’s TA Score shows that 4 TA indicator(s) are bullish while SNSE’s TA Score has 3 bullish TA indicator(s).

  • FATE’s TA Score: 4 bullish, 4 bearish.
  • SNSE’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, FATE is a better buy in the short-term than SNSE.

Price Growth

FATE (@Biotechnology) experienced а -16.13% price change this week, while SNSE (@Biotechnology) price change was -23.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.27%. For the same industry, the average monthly price growth was -7.37%, and the average quarterly price growth was -12.08%.

Reported Earning Dates

FATE is expected to report earnings on Apr 30, 2025.

SNSE is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-5.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FATE($88.2M) has a higher market cap than SNSE($9.21M). SNSE YTD gains are higher at: -29.606 vs. FATE (-54.115). SNSE has higher annual earnings (EBITDA): -28.38M vs. FATE (-176.58M). FATE has more cash in the bank: 279M vs. SNSE (47M). SNSE has less debt than FATE: SNSE (4.47M) vs FATE (85.3M). FATE has higher revenues than SNSE: FATE (13.6M) vs SNSE (0).
FATESNSEFATE / SNSE
Capitalization88.2M9.21M958%
EBITDA-176.58M-28.38M622%
Gain YTD-54.115-29.606183%
P/E RatioN/AN/A-
Revenue13.6M0-
Total Cash279M47M594%
Total Debt85.3M4.47M1,909%
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FATESNSE
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 22 days ago
85%
Bullish Trend 13 days ago
73%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HUBC3.010.14
+4.97%
Hub Cyber Security Ltd
DORM122.642.10
+1.74%
Dorman Products
MGA34.220.23
+0.68%
Magna International
AOSL24.910.05
+0.20%
Alpha and Omega Semiconductor Limited
EXFY2.95-0.09
-2.96%
Expensify

SNSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNSE has been loosely correlated with VSTM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SNSE jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNSE
1D Price
Change %
SNSE100%
-12.44%
VSTM - SNSE
47%
Loosely correlated
-3.48%
ALZN - SNSE
40%
Loosely correlated
+4.94%
GRI - SNSE
39%
Loosely correlated
-36.88%
FATE - SNSE
36%
Loosely correlated
-4.18%
GOSS - SNSE
34%
Loosely correlated
-9.61%
More